A phase I/II study of LY900003, an antisense inhibitor of protein kinase C-alpha, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer (Q33362997)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I/II study of LY900003, an antisense inhibitor of protein kinase C-alpha, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer |
scientific article |
Statements
1 reference
A phase I/II study of LY900003, an antisense inhibitor of protein kinase C-alpha, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer (English)
1 reference
Miguel A Villalona-Calero
1 reference
Paul Ritch
1 reference
Jose A Figueroa
1 reference
Gregory A Otterson
1 reference
Robert Belt
1 reference
Edward Dow
1 reference
Sebastian George
1 reference
James Leonardo
1 reference
Spence McCachren
1 reference
G Lance Miller
1 reference
Manuel Modiano
1 reference
Manuel Valdivieso
1 reference
Richard Geary
1 reference
Jennifer W Oliver
1 reference
Jon Holmlund
1 reference
1 September 2004
1 reference
1 reference
Identifiers
1 reference